The Lewis blood group has been described as a new genetic marker of ischaemic heart disease' and alcohol has been claimed to be particularly protective to those with the Lewis phenotype associated with the highest predicted risk.2 These results come from the Copenhagen Male Study, which has followed a cohort of 5249 men since 1970. In 1985 all survivors were traced and 3387 men aged 53-75 years agreed to participate in a further four year prospective study. Several factors were recorded including alcohol and tobacco consumption, physical activity, height, weight, and blood pressure. Blood was taken for several investigations including lipids and Lewis phenotypes. At baseline those who had Lewis blood group Le (a -b -) had a higher serum triglyceride, higher body mass index (BMI, weight/height2), and a lower high density lipoprotein (HDL) cholesterol concentration than those of other Lewis phenotypes. Over the following four years the relative risk of death from ischaemic heart disease was significantly increased in Le (a-b-) individuals, even after correction for baseline age, BMI, HDL cholesterol, and triglyceride.1 Daily consumption of 1 to 4 units alcohol was reported to have a protective effect in those at highest risk of ischaemic heart disease as predicted by their Lewis blood group.2
The Lewis group on red blood cells was first described by Mourant3 19 , and that a polymorphism within it is associated with non insulin dependent diabetes mellitus (NIDDM) with a strong family history.'8 The activity of the enzyme itself seemed to be unrelated to the polymorphism, which was due to a single base change in an intron. It is possible that these polymorphisms are close to a hitherto unidentified gene causing insulin resistance on chromosome 19.
Insulin resistance as a marker of hypothalamic or sympathetic activation Counter-regulatory hormones to insulin, such as adrenaline, noradrenaline, cortisol, growth hormone, and glucagon, can cause insulin resistance through a direct effect on the enzymes involved in glucose homoeostasis in many tissues. The hypothalamic arousal and neuroendocrine dysregulation scheme proposed by Bjorntorp proposes that "stress" may cause insulin resistance by increased hypothalamic arousal.'9 20 The resulting increase in sympathetic activity raises blood pressure, increases hepatic glucose production, and suppresses glycogen synthesis. Several negative feedback loops involving many neurotransmitters are present in the hypothalamus, and abnormalities in pre or post synaptic receptors may affect baseline hypothalamic activity. Genes that cause increased baseline sympathetic outflow will cause hypertension and insulin resistance simultaneously. Such 
